Blood eosinophils predict inhaled fluticasone response in bronchiectasis Source: Eur Respir J, 56 (2) 2000453; 10.1183/13993003.00453-2020 Year: 2020
Blood eosinophils do not predict inhaled budesonide response in bronchiectasis Source: Eur Respir J, 56 (3) 2002210; 10.1183/13993003.02210-2020 Year: 2020
Systemic potency of fluticasone in asthma Source: Eur Respir J, 55 (3) 2000104; 10.1183/13993003.00104-2020 Year: 2020
Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009
Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Eur Respir J 2011; 37: 206-209 Year: 2011
Dose response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Blood eosinophils as a marker of response to inhaled corticosteroids in COPD Source: Eur Respir J 2016; 47:1374-1382 Year: 2016
Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids Source: Eur Respir J 2002; 20: 1364-1369 Year: 2002
Symptoms, induced sputum eosinophil percentages and treatment with salmeterol or fluticasone in mild asthmatics Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002
Influence of large and small dose of fluticasone propionate on clinical symptoms of bronchial asthma, lung function, bronchial hyperreactivity and eosinophilia in induced sputum Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002
Efficacy and systemic effects of ciclesonide and fluticasone in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001
The effect of fluticasone vs fluticasone plus salmeterol on allergen-induced bronchial inflammation in asthmatic patients. A long-term RCT Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004
Effect of salmeterol in asthmatic patients with low sputum eosinophils Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001
Effect of the addition of montelukast to inhaled fluticasone propionate on immunopathology in bronchial biopsies from mild to moderate asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 388s Year: 2002
Alveolar absorption and systemic bioactivity of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 13s Year: 2004
Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition Source: Eur Respir J, 56 (2) 2000237; 10.1183/13993003.00237-2020 Year: 2020
Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma Source: Eur Respir J 2002; 20: 66-72 Year: 2002
Sputum eosinophilia and the response to inhaled corticosteroid (mometasone) in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004